Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Long-Term Deferred Tax (2020 - 2025)

Viemed Healthcare's Long-Term Deferred Tax history spans 6 years, with the latest figure at $5.3 million for Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax fell 37.02% year-over-year to $5.3 million; the TTM value through Dec 2025 reached $5.3 million, down 37.02%, while the annual FY2025 figure was $5.3 million, 37.02% down from the prior year.
  • Long-Term Deferred Tax reached $5.3 million in Q4 2025 per VMD's latest filing, down from $5.7 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $10.4 million in Q2 2025 to a low of $3.1 million in Q4 2022.
  • Average Long-Term Deferred Tax over 5 years is $5.7 million, with a median of $4.7 million recorded in 2021.
  • Peak YoY movement for Long-Term Deferred Tax: crashed 55.32% in 2022, then surged 127.27% in 2025.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $4.8 million in 2021, then tumbled by 34.84% to $3.1 million in 2022, then soared by 46.14% to $4.6 million in 2023, then surged by 84.25% to $8.4 million in 2024, then crashed by 37.02% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Long-Term Deferred Tax are $5.3 million (Q4 2025), $5.7 million (Q3 2025), and $10.4 million (Q2 2025).